Helicos Cuts Q3 Net Loss by Almost 40 Percent; Rules out Potential Sale of Company
November 10, 2009
Helicos Cuts Q3 Net Loss by Almost 40 Percent; Rules out Potential Sale of Company
Helicos said that based on its "improving standalone prospects and current market valuation" that it has disengaged from discussions involving a potential sale of the company.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Latest Sequencer Placement Boosts Helicos Shares
August 20, 2009 / GenomeWeb Daily News - Mass General to Use Helicos Sequencer for Cancer Research
August 18, 2009 / In Sequence - Helicos Sells Sequencer to Undisclosed Biotech Firm
August 4, 2009 / In Sequence - As Helicos Navigates Bankruptcy Process, Details Emerge on Disputes with Creditors and Customers
December 18, 2012 / In Sequence - Paired Ends: Carol Cox, Louise Mawhinney
October 2, 2012 / In Sequence